Company
Tearscience
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
4
510(k), De Novo and PMA
Device trials
6
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
Recall records
2
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$58.9M
2 Form D offerings, 2010 to 2016
Equity
$58.9M
Stock sold for cash
Debt and convertible notes
$0
Loans and notes sold to investors
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $19.2M raised of $29.2M sought, first sale Mar 31, 2016, 14 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
Company details
From the company's latest Form D.
- Legal name
- TearScience, Inc.
- Headquarters
- Morrisville, North Carolina
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Technology
- SEC filer
- CIK 1333252 ↗
Executives, directors and promoters
As listed on the latest Form D.
7 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Tearscience.
Latest FDA decisions
K192623 · Decided Oct 22, 2019 · 29 days after receipt
Device type: Eyelid Thermal Pulsation System (ORZ) · Ophthalmology
K182506 · Decided Dec 10, 2018 · 89 days after receipt
Device type: Camera, Ophthalmic, Ac-Powered (HKI) · Ophthalmology
K161357 · Decided Nov 4, 2016 · 172 days after receipt
Device type: Eyelid Thermal Pulsation System (ORZ) · Ophthalmology
1 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT01808560 · 34 participants · Start Mar 2013 · Primary completion Jan 2015
Device: LipiFlow Pre-Treatment; LipiFlow Post-treatment · For: Blepharitis; Dry Eye Syndrome
Sites: Hoffman Estates, Illinois; Lake Villa, Illinois; Winchester, Massachusetts · 7 sites in all
NCT02102464 · 55 participants · Start Apr 2014 · Primary completion Aug 2015
Device: LipiFlow treatment · For: Meibomian Gland Dysfunction; Dry Eye
Sites: Birmingham, Alabama; Morrow, Georgia; Charlotte, North Carolina · 6 sites in all
NCT00761917 · 229 participants · Start Jun 2008 · Primary completion Oct 2008
Device: Tear Film Analyzer · For: Dry Eye Syndromes
Sites: Fayetteville, Arkansas; Morrow, Georgia; Oak Lawn, Illinois · 8 sites in all
3 more trials with a free account
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 1 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 0 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- LipiFlow Thermal Pulsation System/LipiFlow, System Activator (Disposable), Rx Only, SterileTerminated
Z-1535-2017 · Started Jan 30, 2017 · Posted by FDA Mar 22, 2017
Reason given: Labeling: The labeled storage temperature is not consistent with the temperature conditions tested for the entire four year shelf life duration.
Cause as FDA categorized it: Labeling Change Control · Device type: Eyelid Thermal Pulsation System (ORZ)
Z-0093-2017 · Started Sep 13, 2016 · Posted by FDA Oct 17, 2016
Reason given: Complaints related to an error condition occurring during patient treatment where the FipiFlow System automatically stopped treatment after detecting a problem with the Activator.
Cause as FDA categorized it: Device Design · Device type: Eyelid Thermal Pulsation System (ORZ)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.